Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.
Conditions
- Pancreatic Cancer Metastatic
- Pancreatic Cancer Non-resectable
Interventions
- BIOLOGICAL: individualized anti-tumor new antigen iNeo-Vac-R01 injection
- DRUG: mFOLFIRINOX Treatment Regimen
- DRUG: Sintilimab injection
Sponsor
Zhejiang University
Collaborators